ArcticZymes Technologies ASA (FRA:B4V) Marketable Securities : €6.07 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ArcticZymes Technologies ASA's Marketable Securities for the quarter that ended in Mar. 2024 was €6.07 Mil.

ArcticZymes Technologies ASA Marketable Securities Historical Data

The historical data trend for ArcticZymes Technologies ASA's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Marketable Securities Chart

ArcticZymes Technologies ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

ArcticZymes Technologies ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	6.07

ArcticZymes Technologies ASA Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

ArcticZymes Technologies ASA (FRA:B4V) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

ArcticZymes Technologies ASA Marketable Securities Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

ArcticZymes Technologies ASA (FRA:B4V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

AZT:Norway B4V:Germany

Address

Sykehusveien 23, Tromso, NOR, N-9294

Website

https://www.arcticzymes.com

ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.

ArcticZymes Technologies ASA (FRA:B4V) Headlines

No Headlines